I Kua na'u Advance Care Planning for Native Hawaiian Elders

March 12, 2026 updated by: Tufts Medical Center

I Kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for Native Hawaiian Elders - Trial Phase

Communication surrounding serious illness decision making is formalized in Advance Care Planning (ACP), a process involving verbal or written information designed to inform patients of possible medical options including palliative and hospice care services. Numerous studies have suggested that improved ACP rates better align health care delivery with patient preferences. Despite expansion of ACP services in the health care system, Native Hawaiians (NHs) consistently have negligible rates of ACP and low use of palliative and hospice care services. To address these shortcomings, our multi-disciplinary community and research group has partnered to create the I kua na'u "Let Me Carry Out Your Last Wishes" ACP video intervention. Our Community-Based Collaborative Approach will create, develop and test the I kua na'u comprehensive video-based ACP program honoring the history, opinions, and culture of NHs. Indeed, NH culture is primarily an oral tradition in which the spoken word permeates the life of NHs and is the normal way of interacting with neighbors, including in its most recent adaptation with the use of video media. The I kua na'u program will include videos tailored for the different settings in which older NHs live and get medical care. The videos will explain the importance of ACP, empower NHs to tell their story ('olelo Kama'ilio; "Talk Story") by allowing the recording of personal video declarations of ACP wishes, and the ability to share the personal video declaration with family, friends and clinicians. The overall objective is to conduct a five-year program that includes two years of development of the I kua na'u ACP video program with focus group testing, and then three years of implementation in the NH community. Demonstrating the effectiveness of using the video program in NHs represents an essential step to implement this tool in practice. The Specific Aim is to compare the ACP engagement, knowledge, decisional conflict, and ACP completion rates in 220 NHs over the age of 55 in: (a) a pre-post study design in 110 people living on Homestead or Assisted Living using the video intervention, and (b) a randomized trial of 110 people recruited from Ambulatory Clinics.

Study Overview

Status

Active, not recruiting

Detailed Description

This project entitled, "I kua na'u" in Hawaiian, translates to "Let me carry out your last wishes." This work aims to honor the Native Hawaiian (NH) sense of cultural context for initiating a conversation between elders and their families through a video intervention to promote Advance Care Planning (ACP) in a manner that respectfully communicates the personal preferences of NH elders to their family, caregivers and the health care system. The full I kua na'u program will examine a video enhanced intervention designed by and for Native Hawaiians (NH) and their family caregivers in three distinct settings: 1) NH Homesteads, 2) Assisted Living, and 3) Ambulatory Clinics. The overall objective of the present proposal is to conduct the first phase of the program, which covers the planned two year development period of the I kua na'u ACP video program. During this time, we will conduct a series of focus groups and one-on-one stakeholder interviews to inform the creation of: A) NH ACP videos; B) a NH personal video declaration process; and, C) NH community members training program to deliver the intervention.

Native Hawaiians (NHs), the indigenous people of Hawai'i, comprise a diverse population of more than 500,000 individuals living in the US and are one of the fastest growing racial/ethnic groups in the country. The highest concentration (55%) of NHs live in the State of Hawai'i, the ancestral home of all NH people. Several studies have established a higher mortality rate among NHs that occurs at an age 10-15 years earlier than the general US population. A recent study found that NHs had the lowest life expectancy of the five major ethnic groups in the state of Hawai'i, with a consistent 10-year gap between NHs and the longest living ethnic group. According to the US Census 2010, ~100,000 NHs over the age of 50 currently live in the US with 60% residing in the State of Hawai'i. Yet few studies have examined the use of end-of-life care and advance care planning in NHs who are at high risk for more frequent and earlier age death. Thus, this proposal aims to fill the gap in our understanding of ACP among NH elders and will develop, test and disseminate a culturally informed intervention to improve ACP practices among NH elders and their families.

Mounting evidence suggests that NHs rarely participate in ACP or communicate their ACP wishes to their families, who are often the primary caregivers. Palliative care and hospice services have been associated with less intensive interventions at the end of life, possibly due to improved communication and decision making. Learning about ACP and communicating with family and providers is the best way for a person to get health care that is concordant with one's wishes and values. NHs represent a unique population with distinct cultural, epidemiological, genetic, and psychosocial characteristics. Evidence suggests that they also have distinct health care and health communication preferences. Although some of these distinct features and preferences may contribute to disparities in health care for NHs with advanced illness, these disparities may also be due to identified health communication gaps.

While the topic of ACP communication specifically is understudied, critical health communication gaps exist for many NHs. Previous research by members of this study team and others have identified relevant health communication challenges in NH communities. For instance, practical challenges included jargon and lack of plain English. Interpersonal issues included doctors rushing, doctors not assessing comprehension, and doctors not treating respondents as people. Respondents noted that they would often not ask questions even when they knew they did not understand because they did not want the provider to think negatively of them. Overarching themes to improve communication gaps included: the importance of family and community in health information dissemination, the importance of personal experience and relationships to the salience of health information, and the desire for local cultural relevance in health communication.

ACP seeks to ensure that patients receive medical care consistent with their values, goals and preferences during the advanced stages of a disease when they no longer have capacity to make decisions. ACP is the most consistent factor associated with better end-of-life outcomes in patients with advanced illness and their caregivers. The lack of ACP is associated with more aggressive interventions, more terminal hospitalizations, lower hospice use, and worse caregiver burden and family bereavement outcomes. Unfortunately, ACP completion remains inadequate, and has remained consistently low. Studies show that traditional written and verbal ACP does not effectively inform many patients and caregivers, and often occurs late in the disease process, which is especially true in vulnerable communities such as NHs. Other common barriers to ACP include lack of tailoring for NHs, variable quality of clinician communication, complex relationships between families and clinicians regarding decision making, and the inability for patients to realistically envision accurate future health states. These barriers present challenges as well as an opportunity. This opportunity for change is a major goal of this proposal to evaluate not just an intervention and its meaningfulness to individuals, caretakers, and family, but also, to educate and train our communities on how to deploy the intervention in real world settings. Individuals from our NH communities will be trained to carry out the intervention and to implement this training using our community peer-to-peer model.

Study Type

Interventional

Enrollment (Estimated)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hawaii
      • Honolulu, Hawaii, United States, 96822-2234
        • University of Hawaii

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Subject Inclusion criteria:

  1. NH adult > 55 years of age;
  2. Pre-existing relationship with a primary care provider (PCP, minimum of two prior visits to PCP);
  3. Referral by collaborating community organization.

Subject Exclusion Criteria:

  1. inability to view videos due to visual impairment (worse than 20/200 corrected);
  2. psychological state not appropriate for ACP discussions as determined by RA or clinician;
  3. cognitive impairment (≥2 errors) as assessed by the validated Short Portable Mental Status Questionnaire.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Pre-Post Trial
Native Hawaiian participants from Homestead and Group Assisted Living (N=110) will partake in a pre-post study design. Participants will receive a baseline survey (as described below), view the ACP video intervention, and receive a post-intervention survey, which includes the same items as the baseline survey. In-person or phone interviews will be done at three and six months.
A combination of Native Hawaiian advance care planning video decision support tool and personalized video declarations shared with providers and family members.
No Intervention: Randomized Clinical Trial: Control Group
In the ambulatory clinics we will conduct a randomized controlled trial (N=110), and randomize (1:1) to either the video (intervention) or usual care (control) arm. The control group will receive usual care. All participants will have a baseline survey, be randomized to intervention or control, and receive a post-intervention survey, which includes the same items as the baseline survey. Follow-up in person or by phone interviews will be done at three and six months.
Experimental: Randomized Clinical Trial: Intervention Group
In the ambulatory clinics we will conduct a randomized controlled trial (N=110), and randomize (1:1) to either the video (intervention) or usual care (control) arm. The intervention group will use the ACP video decision aid. All participants will have a baseline survey, be randomized to intervention or control, and receive a post-intervention survey, which includes the same items as the baseline survey. Follow-up in person or by phone interviews will be done at three and six months.
A combination of Native Hawaiian advance care planning video decision support tool and personalized video declarations shared with providers and family members.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in ACP Knowledge (Pre-Post Trial)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
Six questions regarding knowledge of ACP which were used and validated in previous studies will be asked. A score of 0-6 will be assigned. Higher scores indicate more knowledge. Questions will be asked before and after the intervention is administered.
Baseline, 6 weeks, 3 months, 6 months
Change in ACP Knowledge (RCT)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
Six questions regarding knowledge of ACP which were used and validated in previous studies will be asked. A score of 0-6 will be assigned. Higher scores indicate more knowledge.
Baseline, 6 weeks, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in End of Life Health Care Preferences (Pre-Post Trial)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
Participants will be asked 2 questions about their end of life health care preferences. Any change in response will be coded as a change. Questions will be asked before and after the intervention is administered.
Baseline, 6 weeks, 3 months, 6 months
Change in Decisional Conflict (Pre-Post Trial)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
Decisional conflict will be measured with a 2 question survey that returns a score of 0-10. Higher scores indicate more conflict. Questions will be asked before and after the intervention is administered.
Baseline, 6 weeks, 3 months, 6 months
Change in Advance Care Planning Engagement (Pre-Post Trial)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
Four validated likert scale questions regarding ACP engagement are averaged to return an overall score of 0-5. Higher scores indicate increased engagement. Questions will be asked before and after the intervention is administered.
Baseline, 6 weeks, 3 months, 6 months
Change in End of Life Health Care Preferences (RCT)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
Participants will be asked 2 questions about their end of life health care preferences. Any change in response will be coded as a change. Comparison will be post-intervention vs control.
Baseline, 6 weeks, 3 months, 6 months
Change in Decisional Conflict (RCT)
Time Frame: Baseline, six weeks, 3 months, 6 months
Decisional conflict will be measured with a 2 question survey that returns a score of 0-10. Higher scores indicate more conflict. Comparison will be post-intervention vs control.
Baseline, six weeks, 3 months, 6 months
Change in Advance Care Planning Engagement (RCT)
Time Frame: Baseline, six weeks, 3 months, 6 months
Four validated likert scale questions regarding ACP engagement are averaged to return an overall score of 0-5. Higher scores indicate increased engagement. Comparison will be post-intervention vs control.
Baseline, six weeks, 3 months, 6 months
Consumer Assessment of Healthcare Providers and Systems Survey (RCT)
Time Frame: 6 weeks post enrollment
11 questions from the validated AHRQ survey that asks patients to report on their experiences with providers and staff in primary care settings.
6 weeks post enrollment
Consumer Assessment of Healthcare Providers and Systems Survey (Pre-Post Trial)
Time Frame: 6 weeks post enrollment
11 questions from the validated AHRQ survey that asks patients to report on their experiences with providers and staff in primary care settings.
6 weeks post enrollment
Video Preferences (RCT)
Time Frame: 6 weeks post enrollment
4 questions to determine the participant's level of comfort in watching the video.
6 weeks post enrollment
Video Preferences (Pre-Post Trial)
Time Frame: 6 weeks post enrollment
4 questions to determine the participant's level of comfort in watching the video.
6 weeks post enrollment
ACP Documentation (RCT)
Time Frame: 12 months post enrollment
2 questions about whether the participant has had a conversation about ACP with either a provider or a friend/family member, as well as a EHR review for specific documentation of ACP preferences (intubation, DNR, dialysis, POLST, health care proxy).
12 months post enrollment
ACP Documentation (Pre-Post Trial)
Time Frame: 12 months post enrollment.
2 questions about whether the participant has had a conversation about ACP with either a provider or a friend/family member.
12 months post enrollment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Paasche-Orlow, MD, MPH, Tufts Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 16, 2023

Primary Completion (Estimated)

March 31, 2026

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

February 20, 2021

First Submitted That Met QC Criteria

February 23, 2021

First Posted (Actual)

February 25, 2021

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • H-41343
  • 1R01NR018400 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advance Care Planning

Subscribe